A retrospective ,multicenter, cohort trial to evaluate the efficacy and safety of telaprevir versus simeprevir based triple therapy in patients with hepatitis C after living donor liver transplantation

Trial Profile

A retrospective ,multicenter, cohort trial to evaluate the efficacy and safety of telaprevir versus simeprevir based triple therapy in patients with hepatitis C after living donor liver transplantation

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Dec 2016

At a glance

  • Drugs Simeprevir (Primary) ; Telaprevir (Primary) ; Peginterferon alfa-2a; Peginterferon alfa-2b; Ribavirin
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Dec 2016 Results assessing efficacy and safety published in the Hepatology Research.
    • 18 Apr 2016 New trial record
    • 01 Mar 2016 Results published in the Hepatology Research
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top